Blackmores Limited (ASX:BKL – Get Rating) insider Anne Templeman-Jones bought 320 shares of the stock in a transaction that occurred on Thursday, September 1st. The shares were bought at an average price of A$67.68 ($47.33) per share, for a total transaction of A$21,656.96 ($15,144.73).
Blackmores Price Performance
The company has a debt-to-equity ratio of 6.18, a current ratio of 2.34 and a quick ratio of 1.27.
Blackmores Cuts Dividend
The firm also recently disclosed a Final dividend, which will be paid on Sunday, September 18th. Stockholders of record on Sunday, September 18th will be given a $0.32 dividend. The ex-dividend date of this dividend is Tuesday, August 30th. This represents a dividend yield of 0.46%. Blackmores’s payout ratio is 60.51%.
Blackmores Company Profile
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and internationally. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; essentials; everyday health; and eye health.
- MarketBeat Podcast: Stock Market, Bad News is Good News
- Forget Bitcoin, Block’s Ecosystems are the Real Growth Drivers
- What Does an Inverted Yield Curve Mean For You?
- SPY vs. QQQ: Which ETF Wins in 2022?
- Could Snap Stock Rebound As Management Restructures?
Receive News & Ratings for Blackmores Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackmores and related companies with MarketBeat.com's FREE daily email newsletter.